PharmaCare Drug Coverage Decision Summaries

Drug Coverage Decision Summaries provide explanations of some PharmaCare drug coverage decisions and include information about:

the drug
the disease or condition the drug is used to treat
PharmaCare’s coverage decision
the reasons this drug is or is not being covered by PharmaCare

Note: Not all drugs that have been reviewed have a Drug Coverage Decision Summary document, but new decision summaries are added regularly.

Click on a generic name in the table below to see the Drug Coverage Decision Summary for that drug and indication.

Click here to see the table below sorted by brand name.

Generic Name	Brand Name	Indication	PharmaCare Decision Date
adalimumab (PDF 109K)	Humira®	difficult to treat Crohn’s disease	09-Sep-2008
adefovir (PDF 190K)	Hepsera®	chronic hepatitis B	27-Mar-2008
aprepitant (PDF 427K)	Emend®	for prevention of vomiting in patients with cancer	16-Mar-2010
ciprofloxacin + dexamethasone [ear drops] (PDF 72K)	Ciprodex®	acute otitis media with otorrhea and otitis externa	18-Jul-2005
clopidogrel (1) (PDF 68K)	Plavix®	after drug-eluting stent insertion	18-Feb-2008
clopidogrel (2) (PDF 182K)	Plavix®	Acute Coronary Syndrome	16-Mar-2010
clostridium botulinum neurotoxin type A, with complexing proteins (PDF 403K)	Xeomin®	muscle spasticity	15-Jun-2010
delta-9-tetrahydrocannabinol + cannabidiol (1) (PDF 67K)	Sativex®	adjunctive neuropathic pain relief in multiple sclerosis	23-Dec-2008
delta-9-tetrahydrocannabinol + cannabidiol (2) (PDF 67K)	Sativex®	adjunctive pain relief in advanced cancer	23-Dec-2008
entecavir (PDF 133K)	Baraclude™	chronic hepatitis B in patients who develop cirrhosis	27-Mar-2008
ezetimibe (1) (PDF 64K)	Ezetrol®	hypercholesterolemia	08-Nov-2007
ezetimibe (2) (PDF 96K)	Ezetrol®	high cholesterol in patients with specific variants of NPC1L1 protein	10-Sep-2008
gliclazide (PDF 67K)	Diamicron®	type 2 diabetes	08-Jul-2008
imiquimod (PDF 459K )	Aldara®	actinic keratosis on the face or balding scalp	28-Jun-2010
insulin glulisine (PDF 67K)	Apidra™	type 1 or type 2 diabetes mellitus	01-Jun-2009
interferon beta-1b injection (PDF 69K)	Betaseron®	early treatment before a definite diagnosis of multiple sclerosis	23-Dec-2008
levodopa + carbidopa + entacapone (PDF 103K)	Stalevo®	hard-to-treat Parkinson’s Disease	05-Jun-2009
levofloxacin (PDF 475K)	Levaquin®	short-course airway infections	14-Jan-2009
lovastatin + niacin (PDF 66K )	Advicor®	high cholesterol	03-Mar-2008
moxifloxacin (PDF 559K)	Avelox®	airway infections	15-Jan-2009
oxybutynin (controlled-release) (PDF 66K)	Uromax®	overactive bladder	27-Feb-2008
ramipril + hydrochlorothiazide (PDF 65K)	Altace HCT®	hypertension	17-Dec-2008
telbivudine (PDF 138K)	Sebivo®	chronic hepatitis B infection in patients with liver disease	27-Mar-2008

To return to the Drug Review Results & Process home page click here.